Agile Therapeutics Inc (AGRX)
0.368
0.00 (0.00%)
USD |
OTCM |
Apr 19, 10:37
Agile Therapeutics Total Assets (Quarterly): 10.26M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.26M |
| September 30, 2023 | 10.89M |
| June 30, 2023 | 12.57M |
| March 31, 2023 | 13.70M |
| December 31, 2022 | 14.24M |
| September 30, 2022 | 18.46M |
| June 30, 2022 | 32.83M |
| March 31, 2022 | 29.30M |
| December 31, 2021 | 39.33M |
| September 30, 2021 | 36.68M |
| June 30, 2021 | 52.28M |
| March 31, 2021 | 59.48M |
| December 31, 2020 | 73.06M |
| September 30, 2020 | 89.41M |
| June 30, 2020 | 103.06M |
| March 31, 2020 | 108.89M |
| December 31, 2019 | 49.54M |
| September 30, 2019 | 33.83M |
| June 30, 2019 | 24.92M |
| March 31, 2019 | 26.13M |
| December 31, 2018 | 22.39M |
| Date | Value |
|---|---|
| September 30, 2018 | 31.60M |
| June 30, 2018 | 36.61M |
| March 31, 2018 | 42.92M |
| December 31, 2017 | 50.60M |
| September 30, 2017 | 58.41M |
| June 30, 2017 | 47.25M |
| March 31, 2017 | 56.62M |
| December 31, 2016 | 63.87M |
| September 30, 2016 | 67.11M |
| June 30, 2016 | 73.64M |
| March 31, 2016 | 80.86M |
| December 31, 2015 | 50.42M |
| September 30, 2015 | 55.09M |
| June 30, 2015 | 61.67M |
| March 31, 2015 | 68.70M |
| December 31, 2014 | 54.83M |
| September 30, 2014 | 60.86M |
| June 30, 2014 | 66.27M |
| March 31, 2014 | 15.99M |
| December 31, 2013 | 14.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.26M
Minimum
Dec 2023
108.89M
Maximum
Mar 2020
42.78M
Average
33.83M
Median
Sep 2019
Total Assets (Quarterly) Benchmarks
| Altimmune Inc | 210.64M |
| iBio Inc | 34.02M |
| Ampio Pharmaceuticals Inc | 5.736M |
| Oragenics Inc | 4.966M |
| Actinium Pharmaceuticals Inc | 81.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.57M |
| Shareholders Equity (Quarterly) | -16.32M |
| Debt to Equity Ratio | -0.1045 |
| Current Ratio | 0.4587 |
| Net Debt Paydown Yield | -1.34% |